Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biochemical Characterizations of Human TMPK Mutations Identified in Patients with Severe Microcephaly: Single Amino Acid Substitutions Impair Dimerization and Abolish Their Catalytic Activity. | ACS Omega | 2021 | 34926941 | PubTator, text mining | PubMed |
| Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature. | Pharmgenomics Pers Med | 2021 | 34916829 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| A narrative review of genetic factors affecting fluoropyrimidine toxicity. | Precis Cancer Med | 2021 | 34901834 | PubTator, text mining | PubMed |
| Advances and challenges in the treatment of esophageal cancer. | Acta Pharm Sin B | 2021 | 34900524 | PubTator, text mining | PubMed |
| Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives. | Mutat Res Rev Mutat Res | 2021 | 34893156 | PubTator, text mining | PubMed |
| Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer. | Front Cell Dev Biol | 2021 | 34881242 | PubTator, text mining | PubMed |
| Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China. | Pharmgenomics Pers Med | 2021 | 34876832 | PubTator, text mining | PubMed |
| Early and late recurrences in lymph node-negative gastric cancer: a retrospective cohort study. | Ann Saudi Med | 2021 | 34873937 | PubTator, text mining | PubMed |
| The cytosolic iron-sulfur cluster assembly (CIA) pathway is required for replication stress tolerance of cancer cells to Chk1 and ATR inhibitors. | NPJ Breast Cancer | 2021 | 34857765 | PubTator, text mining | PubMed |
| Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck. | ESMO Open | 2021 | 34844180 | PubTator, text mining | PubMed |
| Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder. | Mob DNA | 2021 | 34838103 | PubTator, text mining | PubMed |
| LIN28B Enhanced STAT3 Signaling Regulates Inflammatory Response and Chemotherapeutic Resistance in Cholangiocytes. | Asian Pac J Cancer Prev | 2021 | 34837926 | PubTator, text mining | PubMed |
| PharmVIP: A Web-Based Tool for Pharmacogenomic Variant Analysis and Interpretation. | J Pers Med | 2021 | 34834582 | PubTator, text mining | PubMed |
| Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study. | J Pers Med | 2021 | 34834543 | PubTator, text mining | PubMed |
| Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy. | J Pers Med | 2021 | 34834445 | PubTator, text mining | PubMed |
| Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. | Cells | 2021 | 34831211 | PubTator, text mining | PubMed |
| Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives. | Cancers (Basel) | 2021 | 34830815 | PubTator, text mining | PubMed |
| Sulfur Administration in Fe-S Cluster Homeostasis. | Antioxidants (Basel) | 2021 | 34829609 | PubTator, text mining | PubMed |
| Borderline Personality Disorder: Risk Factors and Early Detection. | Diagnostics (Basel) | 2021 | 34829488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=53